Endogenous opioid system in developing normal and jimpy oligodendrocytes: μ and κ opioid receptors mediate differential mitogenic and growth responses

GLIA

Volumn 22, Issue 2, 1998, Pages 189-201

  Knapp, Pamela E ^a,c   Maderspach, Katalin ^b   Hauser, Kurt F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; BROXURIDINE; DIAGNOSTIC AGENT; ENDORPHIN; KAPPA OPIATE RECEPTOR; MITOGENIC AGENT; MORPHICEPTIN, N ME PHE(3); MORPHICEPTIN, N-ME-PHE(3)-; MU OPIATE RECEPTOR; OPIATE RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL SIZE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE MUTANT; NEWBORN; OLIGODENDROGLIA; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; ANTIMETABOLITES; BROMODEOXYURIDINE; CELL SIZE; CELLS, CULTURED; ENDORPHINS; IMMUNOHISTOCHEMISTRY; MICE; MICE, JIMPY; MITOGENS; OLIGODENDROGLIA; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0032004982     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199802)22:2<189::AID-GLIA10>3.0.CO;2-U     Document Type: Article

References (52)

1. Arvidsson, U., Dado, R.J., Riedl, M., Lee, J.-H., Law, P.-Y., Loh, H.H., Elde, R., and Wessendorf, M.W. (1995a) δ opioid receptor immunoreactivity: Distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J. Neurosci., 15:1215-1235.
2. Arvidsson, U., Riedl, M., Chakrabarti, S., Lee, J.-H., Nakano, A.H., Dado, R.J., Loh, H.H., Law, P.-Y., Wessendorf, M.W., and Elde, R. (1995b) Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci., 15:3328-3341
3. Arvidsson, U., Riedl, M., Chakrabarti, S., Vulchanova, L., Lee, J.-H., Nakano, A.H., Lin, X., Loh, H.H., Law, P.-Y., Wessendorf, M.W., and Elde, R. (1995c) The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc. Natl. Acad. Sci., USA, 92:5062-5066.
4. Bansal, R., Warrington, A., Gard, A., Ranscht, B., and Pfeiffer, S. (1989) Multiple and novel specificities of monoclonal antibodies O1, O4 and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res., 24:548-557.
5. Barg, J., Nah, S.-Y., Levy, R., Saya, D., and Vogel, Z. (1993) Modulation of thymidine incorporation by kappa-opioid ligands in rat spinal cord-dorsal root ganglion co-cultures. Brain Res., 629:109-114.
6. Barres, B.A., Lazar, M.A., and Raff, M.C. (1994) A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development, 120:1097-1108.
7. Bartlett, W.P., Knapp, P.E., and Skoff, R.P. (1988) Glial conditioned medium enables jimpy oligodendroglia to express properties of normal oligodendrocytes: Production of myelin antigens and membranes. Glia, 1:253-259.
8. Carson, M.J., Behringer, R.R., Brinster, R.L., and McMorris, F.A. (1993) Insulin-like growth factor 1 increases brain growth and central nervous system myelination in transgenic mice. Neuron, 10:729-740.
9. Dodge Miller, C.R., O'Steen, W.K., and Deadwyler, S.A. (1982) Effect of morphine on 3H-thymidine incorporation in the subependyma of the rat: an autoradiographic study. J. Comp. Neurol., 208:209-214.
10. Duncan, I.D., Hammang, J.P., Goda, S., and Quarles, R.H. (1989) Myelination in the jimpy mouse in the absence of proteolipid protein. Glia, 2:148-154.
11. Ela, C., Hasin, Y., and Eilam, Y. (1993) Opioid effects on contractility, Ca(2+)- transients and intracellular pH in cultured cardiac myocytes. J. of Mol. Cell. Cardiol., 25:599-613.
12. Eriksson, P.S., Hansson, E., and Ronnback, L. (1990) δ and κ opiate receptors in primary astroglial cultures from rat cerebral cortex. Neurochem. Res., 15:1123-1126.
13. Eriksson, P.S., Hansson, E., and Ronnback, L. (1991) Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain - coupling with adenylate cyclase, localization on the same neurones and association with dopamine (D1) receptor adenylate cyclase. Neuropharmacology, 30:1233-1239.
14. Evans, C.J. (1993) Diversity among the opioid receptors. Biological Basis of Substance Abuse. S.G. Korenman and J.D. Barchas, eds. Oxford University Press, New York, 31-48.
15. Ghandour, M.S. and Skoff, R.P. (1988) Expression of galactocerebroside in developing normal and jimpy oligodendrocytes in situ. J. Neurocytol., 17:485-498.
16. Grinspan, J., Wrabetz, L., and Kamholz, J. (1993) Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. J. Neurocytol., 22:322-333.
17. Gurwell, J.A., Duncan, M.J., Maderspach, K., Steine-Martin, A., Elde, R.P., and Hauser, K.F. (1996) κ-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: Relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids. Brain Res., 737:175-187.
18. Hauser, K.F. and Steine-Martin, A. (1993) Opiates and the regulation of nervous system development: Evidence from in vitro studies. The Neurobiology of Opiates. R.P. Hammer Jr., ed. CRC Press, Boca Raton, 23-61.
19. Hauser, K.F. and Mangoura, D. (1997) Diversity of the endogenous opioid system in development: novel signal transduction translates multiple extracellular signals into neural cell growth and differentiation. Perspect. Dev. Neurobiol., 4, in press.
20. Hauser, K.F., Osborne, J.G., Steine-Martin, A., and Meiner, M.H. (1990) Cellular localization of proenkephalin mRNA and enkephalin peptide products in cultured astrocytes. Brain Res., 522:347-353.
21. Hauser, K.F., Gurwell, J.A., and Bhat, N.R. (1993) Endogenous opioid systems and the growth of oligodendrocyte progenitors: Paradoxical increases in oligodendrogenesis as an indirect mechanism of opioid action. Glia, 9:157-162.
22. Hauser, K.F., Steine-Martin, A., Mattson, M.P., Elde, R.P., Ryan, S.E., and Godleske, C.C. (1996) μ-opioid receptor-induced Ca2+ mobilization and astroglial development: Morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca2+ dependent mechanism. Brain Res., 270:191-203.
23. Hudson, L.D., Berndt, J.A., Puckett, C., Kozak, C.A., and Lazzarini, R.A. (1987) Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse. Proc. Nati Acad. Sci. USA, 84:1454-1458.
24. Knapp, P.E. (1992) The cell cycle of glial cells grown in vitro: An immunocytochemical method of analysis. J. Histochem. Cytochem., 40:1405-1411.
25. Knapp, P.E. and Skoff, R.P. (1987) A defect in the cell cycle of neuroglia in the myelin deficient jimpy mouse. Dev. Brain Res., 35:301-306.
26. Knapp, P.E. and Skoff, R.P. (1993) Jimpy mutation affects astrocytes: Lengthening of the cell cycle in vitro. Dev. Neurosci., 15:31-36.
27. Knapp, P.E. and Williams, L.A. (1994) Apoptosis of glial cells from brains of normal and hypomyelinating jimpy mice: In vivo and in vitro studies. J. Neurochem., 54:S97A.
28. Knapp, P.E. and Hauser, K.F. (1996) μ-opioid receptor activation enhances DNA synthesis in immature oligodendrocytes. Brain Res., 743:341-345.
29. Knapp, P.E., Skoff, R.P., and Redstone, D.W. (1986) Oligodendroglial cell death in jimpy mice: An explanation for the myelin deficit. J. Neurosci., 6:2813-2822.
30. Knapp, P.E., Bartlett, W.P., and Skoff, R.P. (1987) Cultured oligodendrocytes mimic in vivo characteristics: Cell shape, expression of myelin specific antigens and membrane production. Dev. Biol., 120:356-365.
31. Knapp, P.E., Booth, C.S., and Skoff, R.P. (1993) The pH of jimpy glia is increased: Intracellular measurements using fluorescent laser cytometry. Intl. J. Develop. Neurosci., 11:215-226.
32. Knapp, P.E., Skoff, R.P., and Benjamins, J.A. (1996) Epigenetic factors upregulate expression of myelin proteins in the dysmyelinating jimpy mutant mouse. J. Neurobiol., 29:138-150.
33. Leng, G., Bicknell, R.J., Brown, D., Bowden, C., Chapman, C., and Russell, J.A. (1994) Stimulus-induced depletion of pro-enkephalins, oxytocin, and vasopressin and pro-enkephalin interaction with posterior pituitary hormone release in vitro. Neuroendocrinology, 60:559-566.
34. Maderspach, K., Nemeth, K., Simon, J., Benyhe, S., Szucs, M., and Wollemann, M. (1991) Amonoclonal antibody recognizing κ- but not μ- and δ-opioid receptors. J. Neurochem., 56:1897-1904.
35. McKinnon, R.D., Matsui, T., Dubois-Dalcq, M., and Aaronson, S.A. (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron, 5:603-614.
36. McKinnon, R.D., Piras, G., Ida Jr., J.A., and Dubois-Dalcq, M. (1993) A role for TGF-β in oligodendrocyte differentiation. J. Cell Biol., 121:1397-1407.
37. Meiner, M.H., Low, K.G., Allen, R.G., Nielson, C.P., Young, S.L., and Saneto, R.P. (1990) The regulation of proenkephalin expression in a distinct population of glial cells. EMBO J., 9:791-796.
38. Nave, K.-A., Lai, C., Bloom, P.E., and Milner, R.J. (1986) Jimpy mutant mouse: A 74 base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in RNA splicing. Proc. Natl. Acad. Sci. USA, 83:9264-9268.
39. Periyasamy, S.M. (1992) Inhibition of cardiac sarcolemmal Na+/H+ antiporter by opioids. Can. J. Physiol. Pharmacol., 70:1048-1056.
40. Ruzicka, B.B., Fox, C.A., Thompson, R.C., Meng, F., Watson, S.J., and Akil, H. (1995) Primary astroglial cultures derived from several rat brain regions differentially express μ, δ, and κ opioid receptor mRNA. Molec. Brain Res., 34:209-220.
41. Ruzicka, B.B., Thompson, R.C., Watson, S.J., and Akil, H. (1996) Interleukin-1β-mediated regulation of μ-opioid receptor mRNA in primary astrocyte-enriched cultures. J. Neurochem., 66:425-428.
42. Schwartz, J.P., Nishiyama, N., Wilson, D., and Taniwaki, T. (1994) Receptor-mediated regulation of neuropeptide gene expression in astrocytes. Glia, 11:185-190.
43. Shinoda, H., Marini, A.M., Cosi, C., and Schwartz, J.P. (1989) Brain region and gene specificity of neuropeptide gene expression in cultured astrocytes. Science, 245:415-417.
44. Skoff, R.P. (1982) Increased proliferation of oligodendrocytes in the hypomyelinated mouse mutant-jimpy. Brain Res., 248:19-31.
45. Skoff, R.P. and Knapp, P.E. (1992) Phenotypic expression of X-linked genetic defects affecting myelination. Myelin: Biology and Chemistry. R. Martenson, ed. CRC Press, Boca Raton, pp. 653-676.
46. Sommer, I. and Schachner, M. (1982) Cells that are O4 antigen-positive and O1 antigen-negative differentiate into O1 antigen-positive oligodendrocytes. Neurosci. Lett., 29:183-188.
47. Steine-Martin, A. and Hauser, K.F. (1991) Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro. J. Neurosci. Res., 29:538-548.
48. Van Bockstaele, E.J., Colago, E.E.O., Cheng, P., Moriwaki, A., Uhl, G.R., and Pickel, V.M. (1996) Ultrastructural evidence for prominent distribution of the μ-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat locus coeruleus. J. Neurosci., 16:5037-5048.
49. Vela, J.M., Dalmau, I., Gonzalez, B., and Castellano, B. (1996) The microglial reaction in spinal cords of jimpy mice is related to apoptotic oligodendrocytes. Brain Res., 712:134-142.
50. Verity, A.N., Levine, M.S., and Campagnoni, A.T. (1990) Gene expression in the jimpy mutant: Evidence for fewer oligodendrocytes expressing myelin protein genes and impaired translocation of myelin basic protein mRNA. Dev. Neurosci., 12:359-372.
51. Vilijn, M.H., Vaysse, P.J.-J., Zukin, R.S., and Kessler, J.A. (1988) Expression of preproenkephalin mRNA in cultured astrocytes and neurons. Proc. Nat. Acad. Sci. USA, 85:6551-6555.
52. Willard, H.F. and Riordan, J.R. (1985) Assignment of the gene for myelin proteolipid protein to the X chromosome: Implications for X-linked myelin disorders. Science, 230:940-942.